Medicine and Dentistry
Ablation Therapy
11%
Acute Decompensated Heart Failure
21%
Acute Kidney Injury
9%
Amino Terminal Sequence
9%
Antiapoptotic
9%
Anticoagulation
10%
Antithrombotic
22%
Apolipoprotein E
9%
Apoplexy
15%
Atrial Fibrillation
100%
Atrial Fibrillation Ablation
27%
Bepridil
9%
Bone Mass
9%
Brain Natriuretic Peptide
15%
Calcium Signaling
9%
Cardiovascular System
14%
Catheter Ablation
70%
Catheter Ablation
36%
Creatinine
13%
D-Dimer
20%
Defibrillator
9%
Heart Atrium Remodeling
12%
Heart Failure
38%
Heart Failure with Preserved Ejection Fraction
10%
Heart Failure with Reduced Ejection Fraction
25%
Heart Left Ventricle Ejection Fraction
19%
Intracardiac Echocardiography
9%
Life Expectancy
9%
Major Bleeding
11%
Midkine
9%
Mobilization
9%
Observational Study
11%
Oxygen Desaturation
9%
Pathophysiology
12%
Permanent Atrial Fibrillation
9%
Persistent Atrial Fibrillation
14%
Protein Z
9%
Pulmonary Vein Isolation
20%
Recurrent Disease
12%
RNA Synthesis
9%
Sinus Rhythm
15%
Spiral Wave
9%
Sustained Ventricular Tachycardia
11%
Systolic Heart Failure
9%
T Wave
9%
Takotsubo Cardiomyopathy
9%
Transient Ischemic Attack
11%
Urinary System
11%
Ventricular Fibrillation
12%
Ventricular Tachycardia
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
9%
Acute Heart Failure
21%
Acute Kidney Failure
9%
Adverse Outcome
9%
Amiodarone
9%
Antiapoptotic
12%
Anticoagulant Agent
16%
Apolipoprotein E
8%
Apolipoprotein E Knockout Mouse
9%
Atrial Fibrillation
77%
Bepridil
9%
Biological Marker
9%
Bleeding
9%
Brain Natriuretic Peptide
15%
Calcium Ion
9%
Cardiac Sarcoidosis
9%
Cardiovascular Disease
9%
Congestive Heart Failure
19%
Creatinine
15%
D Dimer
11%
Direct Oral Anticoagulant
19%
Fatty Acid Binding Protein
9%
Fibrosis
9%
Heart Failure
32%
Heart Failure with Preserved Ejection Fraction
10%
Heart Failure with Reduced Ejection Fraction
25%
Heart Ventricle Remodeling
9%
Heart Ventricle Tachycardia
13%
Idarucizumab
9%
Inflammation
23%
Left Ventricular Systolic Dysfunction
9%
Leporidae
11%
Life Expectancy
9%
Midkine
19%
Myosin Binding Protein C
9%
Non Insulin Dependent Diabetes Mellitus
9%
Observational Study
11%
Pathophysiology
13%
Pilsicainide
9%
Protein Kinases
9%
Recurrent Disease
12%
Reentry Arrhythmia
9%
Rivaroxaban
19%
Rotigaptide
9%
Sodium Ion
9%
Systolic Heart Failure
11%
Thromboembolism
10%
Transient Ischemic Attack
8%
Transient Receptor Potential Channel 3
9%
Verapamil
9%
Keyphrases
Ablation Index
9%
Acute Kidney Injury
9%
Adenosine Monophosphate
9%
Adverse Outcomes
9%
Amiodarone
9%
Angiogenic
9%
Angiotensin II Type 1 Receptor (AT1R)
9%
Anti-apoptotic
9%
Apolipoprotein E Knockout Mice
9%
Atherosclerotic Plaque Rupture
9%
Atrial Electrophysiology
9%
Atrial Fibrillation
9%
Atrial Fibrillation Progression
9%
Bepridil
9%
Calcium Handling
9%
Calcium Signaling
9%
CAMP-dependent Protein Kinase
9%
Cardiac Disease
9%
Cardiac Fibroblasts
11%
Cardiac Intensive Care Unit
19%
Cell Calcium
9%
Collagen Secretion
9%
Disease Potential
9%
Electrical Coupling
9%
Fatty
9%
Intracardiac Echocardiography
9%
Intracellular Angiotensin
9%
Metabolic Adaptation
9%
MicroRNA Regulation
9%
Midkine
9%
Moderate Hypothermia
9%
Multiple Wavelet
9%
Multiscale Entropy
9%
Oral Anticoagulant Therapy
9%
Oxygen Desaturation
9%
Prognostic Importance
9%
Pulmonary Tumor Thrombotic Microangiopathy
9%
RNA Synthesis
9%
Rotor
9%
Signaling Role
9%
SK Channels
9%
Small RNA Sequencing
9%
Spiral Wave
9%
Spiral Wave Reentry
9%
Takotsubo Cardiomyopathy
9%
Telemonitoring
9%
Unpinning
9%
Urinary Liver-type Fatty Acid Binding Protein
9%
Wave Collision
9%
Wearable Cardioverter Defibrillator
9%